Daniel Henry Mathalon MD
Staff Physician, Mental Health Service, SFVAMC Professor in Residence of Psychiatry and Biomedical Sciences, UCSF
Join to View Full Profile
4150 Clement StMental Health 116d, SfvamcSan Francisco, CA 94121
Phone+1 415-221-4810
Fax+1 415-750-6622
Dr. Mathalon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1994 - 1998
Stanford University School of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 1995 - 2025
CT State Medical License 2001 - 2007
American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program.Tashrif Billah, Kang Ik K Cho, Owen Borders, Yoonho Chung, Michaela Ennis
Schizophrenia. 2025-04-03 - Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.Nora Penzel, Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi
Schizophrenia. 2025-04-03 - Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.Jean Addington, Lu Liu, Amy Braun, Andrea Auther, Monica E Calkins
Schizophrenia. 2025-04-03
Journal Articles
- The Global Functioning: Social and Role Scales—Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for PsychosisDaniel H Mathalon, Ming T Tsuang, Carrie E Bearden, Kristin S Cadenhead, Diana O Perkins, Schizophrenia Bulletin
- A Framework for Linking Resting-State chronnectome/genome Features in Schizophrenia: A Pilot StudyJudith M Ford, Juan R Bustillo, Daniel H Mathalon, Adrian Preda, Kelvin O Lim, ScienceDirect
- American Psychiatric Association PublishingJohn M. Kane, Daniel H. Mathalon, Michael L. Birnbaum, Rachel L. Loewy, The American Journal of Psychiatry
- Join now to see all
Authored Content
- S184. Oxytocin Increases Gaze to the Eyes in SchizophreniaApril 2018
Press Mentions
Brain Wave May Help Predict PsychosisAugust 15th, 2019
Forecasting Psychosis RiskFebruary 10th, 2016
Grant Support
- TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERSUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2000–2027
- Applying Mindfulness-Based Cognitive Therapy To Treatment-Resistant DepressionNational Center For Complementary &Alternative Medicine2011
- Functional Brain Abnormalities In The Schizophrenia ProdromeNational Institute Of Mental Health2008–2011
- Functional Brain Abnormalities In The Schizophrenia ProdromeNational Institute Of Mental Health2007
- Intermittent D1 Agonist Treatment Of Executive Dysfunction In Schizophrenia: A DONational Institute Of Mental Health2004–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
